Over at Chardan Capital, Geulah Livshits reiterated a buy rating and a $25 price target on July 23. From the stock's price of ...

Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm ...

Pop star-slash-psychedelic prince Harry Styles has been a sex symbol for the past decade, both as a member of boy-band ...

KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today ...

For individuals considering cataract surgery in West Fargo, Vance Thompson Vision provides expert surgical care with a strong ...

Fifteen years after Greg left football, on the evening of May 21, 2024, The Ventura County Star published a news roundup ...

Biohaven Ltd., a New Haven-based bioscience firm, its chief executive officer and its chief financial officer are being sued ...

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25 ...

Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...

The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial units to ...

Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter. Shares were ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...